CytoTerra Inc.
PrivateLast Round
Seed
Sep 25, 2026
Momentum
Top 10%
of companies Caplight tracks
Company Overview
CytoTerra Inc. operates in Healthcare & Life Sciences and is based in Seattle, Washington. It was founded in 2025.
CytoTerra Inc. is a diagnostic equipment company that develops a genome-wide cytogenetic assay for the comprehensive detection of chromosomal abnormalities.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Data Visualization
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CytoTerra Inc. Comparables
Compare CytoTerra Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phase Genomics | 85% | |
| Edenroc Sciences | 77% | |
| Arima Genomics | 77% |
For institutional investors. Book with your work email.
CytoTerra Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CytoTerra Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pack Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 25, 2026
$1M raised led by Pack Ventures.
For institutional investors. Book with your work email.
CytoTerra Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CytoTerra Inc.'s valuation, stock price, and market status.
Is CytoTerra Inc. a public or private company?
CytoTerra Inc. is a private company.
What is the current stock price of CytoTerra Inc.?
CytoTerra Inc. is a private company, so its shares have no public market price. Caplight tracks CytoTerra Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CytoTerra Inc. worth (valuation)?
Valuation information for CytoTerra Inc. is not publicly available.
Can I buy CytoTerra Inc. stock?
CytoTerra Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CytoTerra Inc.'s last funding round?
CytoTerra Inc.'s most recent funding round was Seed on September 25, 2026.
Who are the main investors in CytoTerra Inc.?
Key investors in CytoTerra Inc. include Pack Ventures.
Will CytoTerra Inc. IPO soon?
No public IPO plans have been announced for CytoTerra Inc..
How can I track CytoTerra Inc. secondary market activity?
Caplight tracks bids, offers, and trades in CytoTerra Inc.'s shares on secondary markets.